Making Sense of Scents
In a first, UCSF scientists created a molecular-level, 3D picture of how an odor molecule activates a human odorant receptor.
University of California San Francisco
Give to UCSF
Displaying 1 - 30 of 394
-
-
These Morning-After Pills May Prevent S.T.I.s, Researchers Say
-
Doxycycline for STI Prevention: Highly Effective, Minimal Drug Resistance
A sexual health strategy called Doxy-PEP, which involves taking doxycycline after condomless sex, is highly effective in reducing bacterial STIs but is still associated with a limited rise in resistant strains of bacteria.
-
An Allergy Drug Showed Promise for MS. Could They Prove It?
Proof of an over-the-counter allergy drug’s ability to reverse progression of multiple sclerosis provides monumental change for MS patients.
-
What We Were Taught About RNA in High School is Only Half the Picture
Vissers’ work on RNA tags helped found the field of epitranscriptomics, the study of how chemical marks on RNA, rather than their sequence alone, dictate the function of the molecules.
-
Can a Leading Laboratory Unlock the Cause of Gastrointestinal Disease?
Faranak Fattahi’s lab is a national leader in growing stem cells to model peripheral nerves, focusing on gastrointestinal diseases.
-
If Immunity Is Innate, What Impacts Our Ability to Fight Infections?
Balyn Zaro’s lab investigates the cause and consequence of genetic diversity in the immune system, in hopes that her discoveries can lead to better treatments for all patients.
-
Can We Turn Back Time on Age-Related Diseases?
Emily Goldberg's lab studies what happens during aging to a particular set of immune cells: those embedded in fat tissue. She hypothesizes that changes to these cells during aging could be key to age-related inflammation.
-
The Omicron Effect: Can We Predict the Next Viral Killer?
Angela Phillips, PhD, leads research that could help predict future viruses like COVID and the antibodies we might use to treat them.
-
Why Stem Cell Therapy Might Not Work for Older Patients
Leanne Jones, PhD, is at the forefront of studying how stem cells are influenced by their surrounding environment and directed to differentiate into one type of cell or another – research that’s critical for stem cell therapies to be successful.
-
What Enzymes Can Tell Us About Human Health and Global Warming
Because proteins can adapt to extremes, Margaux Pinney, PhD, believes they can show how living organisms might adapt to climate change.
-
‘Bacteria Whisperer’ Aims for New Heights After Winning Top Science Award
Shaeri Mukherjee, PhD, has won the Bowes Biomedical Investigator award, which will provide funding to further her work using bacterial pathogens to identify basic processes inside human cells.
-
Out of Adderall? Tips and Advice During an ADHD Medication Shortage
UCSF experts share insights and tips on supporting children with ADHD amidst a shortage of Adderall and other ADHD medications.
-
After a Decade, CRISPR Gene Editing Is a ‘Revolution in Progress.’ What Does the Future Hold?
-
Is It Safe To Take the Anti-obesity Drug Wegovy Long-term? Doctors Weigh In
-
How One Private Biotech Seized on JPM To Emerge From Stealth and Tell Its Story
-
30 Years On, Are We Winning the Fight Against Alzheimer’s?
UCSF experts discuss the current state of Alzheimer’s treatments and future therapies that may slow progression of the disease.
-
UCSF Researchers Uncover New Pathway for Molecular Cancer Drug Therapies
Researchers have discovered a cellular uptake pathway for larger molecules that delivers cell-permeable drugs efficiently.
-
UCSF Research Crucial to Approval of Breakthrough Diabetes Therapy
Groundbreaking research by UCSF scientists has led to FDA approval of a new therapy that can delay the onset of type 1 diabetes by at least 2 years.
-
Cellular “Glue” to Regenerate Tissues, Heal Wounds, Regrow Nerves
Researchers have engineered molecules that act like “cellular glue,” a major step toward building tissues and organs.
-
Archive Shows How Fentanyl Promotion Helped Drive Opioid Epidemic
New records in the Opioid Industry Documents show that Insys Therapeutics improperly sold vast amounts of its addictive product for off-label uses.
-
F.D.A. Approves a Drug That Can Delay Type 1 Diabetes
-
Myocarditis in Cancer Patients Is Driven by Specific Immune Cells
Researchers have identified specific immune cells that drive deadly heart inflammation in a small fraction of patients treated with powerful cancer immunotherapy drugs.
-
Fatty Liver Linked to Survival in E. Coli Infection
Scientists at UCSF have developed a new way of looking at sex-biased diseases that is rooted in evolutionary biology.
-
Marijuana, Meth, Cocaine and Opiate Use are Linked to Atrial Fibrillation
A new UCSF study researchers of more than 23 million people concludes that some commonly used and abused drugs pose previously unidentified risks for the development of atrial fibrillation (AF), a potentially deadly heart-rhythm disorder.
-
Small-Molecule Drug Reverses Neural Effects of Concussion
A small molecule called ISRIB that was identified at UCSF can reverse the neuronal and cognitive effects of concussion in mice weeks after an injury occurred, new research found.
-
Marijuana Use Linked to Atrial Fibrillation in New UCSF Study
-
New Industry Documents Highlight Role of Pharmacies in Driving Opioid Epidemic
Johns Hopkins University and UCSF, have added new documents to the Opioid Industry Documents Archive that detail the role of retail pharmacies in the opioid overdose epidemic.
-
Single-Celled Organism Uses Internal ‘Computer’ to Walk
The single-celled protozoan Euplotes eurystomus achieves a scurrying walk by coordinate its microscopic uses a simple, mechanical computer instead of a brain like most animals, UCSF researchers found.
-
Non-Opioid Compounds Squelch Pain Without Sedation
A newly identified set of molecules alleviated pain in mice while avoiding the sedating affect that limits the use of opiates, according to a new study led by researchers at UC San Francisco.
